Gastrointestinal Mechanisms Underlying the Cardiovascular Effect of Metformin
Metformin, the most widely prescribed drug therapy for type 2 diabetes, has pleiotropic benefits, in addition to its capacity to lower elevated blood glucose levels, including mitigation of cardiovascular risk. The mechanisms underlying the latter remain unclear. Mechanistic studies have, hitherto,...
Saved in:
| Main Authors: | Malcolm J. Borg (Author), Christopher K. Rayner (Author), Karen L. Jones (Author), Michael Horowitz (Author), Cong Xie (Author), Tongzhi Wu (Author) |
|---|---|
| Format: | Book |
| Published: |
MDPI AG,
2020-11-01T00:00:00Z.
|
| Subjects: | |
| Online Access: | Connect to this object online. |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Enteroendocrine Hormone Secretion and Metabolic Control: Importance of the Region of the Gut Stimulation
by: Cong Xie, et al.
Published: (2020) -
Understanding the action mechanisms of metformin in the gastrointestinal tract
by: Meihui Cheng, et al.
Published: (2024) -
Cardiovascular Effects of Metformin
by: B. T. Kurmanbekova, et al.
Published: (2022) -
Severity of gastrointestinal side effects of metformin tablet compared to metformin capsule in type 2 diabetes mellitus patients
by: Mansour Siavash, et al.
Published: (2017) -
Obesity, Diabetes and Gastrointestinal Malignancy: The role of Metformin and other Anti-diabetic Therapy
by: Michael Ashamalla, et al.
Published: (2018)